Stock MLTX MOONLAKE IMMUNOTHERAPEUTICS
Add to a list
To use this feature you must be a member
Log inSign up

Comparison Chart MoonLake Immunotherapeutics

Equities

MLTX

KY61559X1045

Market Closed - Nasdaq
Other stock markets
 16:00:00 2024-06-18 EDT 		5-day change 1st Jan Change
39.49 USD -1.69% Intraday chart for MoonLake Immunotherapeutics -9.05% -34.61%
06-10 MoonLake Immunotherapeutics Announces Positive Regulatory Feedback from Both FDA and EMA on Path for the Phase 3 Program for the Nanobody Sonelokimab in Psoriatic Arthritis CI
05-07 MoonLake Immunotherapeutics Q1 Net Loss Widens MT
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Compared values

Sector Change 5d. change 1st Jan change 1-year change 5-years change Capi. ST MT LT
MOONLAKE IMMUNOTHERAPEUTICS
Bio Therapeutic Drugs
-1.69%-9.05%-34.61%+51.42% - 2.48B
Neutral
Bearish
Neutral

Technical Rankings Surperformance

  1. Stock Market
  2. Equities
  3. MLTX Stock
  4. Charts MoonLake Immunotherapeutics
  5. Comparison Chart